IL6 and COVID-19: Accordingly, we evaluated the levels of IL-17, IFN-γ, TNF-α, IL-10, IL-6, IL-4 and IL-2 in patients with clinical COVID-19 and long COVID-19, with cases classified as mild, moderate and severe, and associations with risk factors for sex, age and presence of comorbidities.